Capitol Health Limited
(ASX:CAJ) has warned the government’s Mid-Year Economic and Fiscal Outlook could impact company revenue by up to 7 percent.
The company cited changes announced by the government to the bulk-billing incentive program for diagnostic imaging as part of the MYEFO announcement.
The Medtech company said a potential impact on revenue of approximately 5 to 7 percent is possible.
Capitol Health said it will investigate possible remedial options that may be available between now and June 2016.
Capitol Health recorded a net profit of $3.86 million at 30 June 2015.
